Investment Trends In Single Use Systems

As the biopharmaceutical industry's focus moves from a blockbuster sales model to more targeted therapeutics, the need to avoid costly investments in sizable stainless steel equipment is increasing.   The use of single-use bioprocessing equipment is making product manufacture increasingly efficient and frequently less costly, particularly for early stages such as R&D and clinical trials. This is particularly important for smaller and lesser-funded companies, for whom using sin... To continue reading this story Click Here